The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332 · cited 8×
“Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy.”
InfluentialSelf-citation2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Research works printed but not linked: 62
- Maron, 2003, J Am Coll Cardiol, 42, 1687, 10.1016/S0735-1097(03)00941-0 · DOI · Paper page
- Morrow, 1975, Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients, Circulation, 52, 88, 10.1161/01.CIR.52.1.88 · DOI · Paper page
- Agarwal, 2010, Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy, J Am Coll Cardiol, 55, 823, 10.1016/j.jacc.2009.09.047 · DOI · Paper page
- Leonardi, 2010, Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy comparative rates of overall mortality and sudden cardiac death after treatment, Circ Cardiovasc Interv, 3, 97, 10.1161/CIRCINTERVENTIONS.109.916676 · DOI
- Brown, 2011, Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy, J Thorac Cardiovasc Surg, 141, 439, 10.1016/j.jtcvs.2010.04.046 · DOI
- Faber, 2005, Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society, Z Kardiol, 94, 516
- Fernandes, 2005, A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy–the Baylor experience (1996-2002), Clin Cardiol, 28, 124, 10.1002/clc.4960280305 · DOI
- Guo, 2004, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and three-year noninvasive follow-up in 18 patients, Can J Cardiol, 20, 779
- Jensen, 2011, Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study, Circ Cardiovasc Interv, 4, 256, 10.1161/CIRCINTERVENTIONS.110.959718 · DOI
- Jensen, 2011, Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy, Scand Cardiovasc J, 45, 153, 10.3109/14017431.2011.565793 · DOI
- Krejci, 2013, Comparison of long-term effect of dual-chamber pacing and alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy, Sci entificWorldJournal, 2013, 629650
- Malek, 2009, Long-term follow-up of patients with hypertrophic obstructive cardiomyopathy treated with percutaneous alcohol septal ablation, Post Kardiol Interw, 5, 167
- Minami, 2000, Long-term results after myectomy in 64 patients with hypertrophic obstructive cardiomyopathy (HOCM). Morphological and hemodynamic aspects, J Cardiovasc Surg (Torino), 41, 801
- Mohr, 1989, The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. Experience over 15 years, J Thorac Cardiovasc Surg, 97, 666, 10.1016/S0022-5223(19)34512-X · DOI
- Robbins, 1996, Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy, J Thorac Cardiovasc Surg, 111, 586, 10.1016/S0022-5223(96)70310-0 · DOI · Paper page
- Rothlin, 1983, Surgical treatment versus medical treatment in hypertrophic obstructive cardiomyopathy, Eur Heart J, 4, 215, 10.1093/eurheartj/4.suppl_F.215 · DOI
- Schulte, 1999, Management of symptomatic hypertrophic obstructive cardiomyopathy–long-term results after surgical therapy, Thorac Cardiovasc Surg, 47, 213, 10.1055/s-2007-1013146 · DOI
- Seggewiss, 2007, Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy, Clin Res Cardiol, 96, 856, 10.1007/s00392-007-0579-8 · DOI
- Seiler, 1991, Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study, J Am Coll Cardiol, 17, 634, 10.1016/S0735-1097(10)80176-7 · doi:10.1016/s0735-1097(10)80176-7
- Shamim, 2002, Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy, N Engl J Med, 347, 1326, 10.1056/NEJMoa012710 · doi:10.1056/nejmoa012710
- Smedira, 2008, Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy, Ann Thorac Surg, 85, 127, 10.1016/j.athoracsur.2007.07.063 · DOI · Paper page
- Sorajja, 2013, Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Catheter Cardiovasc Interv, 81, 58
- Steggerda, 2014, Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience, J Am Coll Cardiol Intv, 7, 1227, 10.1016/j.jcin.2014.05.023 · DOI
- ten Berg, 1994, Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy, Circulation, 90, 1781, 10.1161/01.CIR.90.4.1781 · DOI
- ten Cate, 2010, Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution, Circ Heart Fail, 3, 362, 10.1161/CIRCHEARTFAILURE.109.862359 · DOI · Paper page
- Veselka, 2006, Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study, Circ J, 70, 1550, 10.1253/circj.70.1550 · doi:10.1253/circj.70.1550
- Sorajja, 2012, Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation, 126, 2374, 10.1161/CIRCULATIONAHA.111.076257 · DOI · Paper page
- Beahrs, 1983, Hypertrophic obstructive cardiomyopathy: ten- to 21-year follow-up after partial septal myectomy, Am J Cardiol, 51, 1160, 10.1016/0002-9149(83)90363-6 · doi:10.1016/0002-9149(83)90363-6
- Zhu, 2006, Surgical outcomes and strategy of hypertrophic obstructive cardiomyopathy, J Zhejiang Univ Sci B, 7, 148, 10.1631/jzus.2006.B0148 · doi:10.1631/jzus.2006.b0148
- Chen, 2006, Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication, Chin Med J, 119, 1121, 10.1097/00029330-200607010-00013 · doi:10.1097/00029330-200607010-00013
- Sathyamurthy, 2014, Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up, Indian Heart J, 66, 57, 10.1016/j.ihj.2013.12.008 · doi:10.1016/j.ihj.2013.12.008
- de la Torre Hernandez, 2014, Effectiveness and safety beyond 10 years of percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy, Rev Esp Cardiol, 67, 353, 10.1016/j.recesp.2013.09.005 · doi:10.1016/j.recesp.2013.09.005
- Fernandes, 2008, Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007, J Am Coll Cardiol Intv, 1, 561, 10.1016/j.jcin.2008.07.005 · DOI
- Guo, 2007, Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy, J Electrocardiol, 40, 356, 10.1016/j.jelectrocard.2006.12.003 · doi:10.1016/j.jelectrocard.2006.12.003
- Jensen, 2013, Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile, Heart, 99, 1012, 10.1136/heartjnl-2012-303339 · DOI
- Klopotowski, 2010, The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy, Clin Res Cardiol, 99, 285, 10.1007/s00392-010-0116-z · DOI
- Lyne, 2010, Long-term follow-up of the first patients to undergo transcatheter alcohol septal ablation, Cardiology, 116, 168, 10.1159/000318307 · DOI
- Samardhi, 2014, The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy, Catheter Cardiovasc Interv, 83, 270
- Sedehi, 2015, Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy, J Cardiol, 66, 57, 10.1016/j.jjcc.2014.08.010 · DOI
- Veselka, 2014, Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population, Eur Heart J, 35, 2040, 10.1093/eurheartj/eht495 · DOI
- Vriesendorp, 2014, Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol HF, 2, 630
- Cohn, 1992, Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy, Am J Cardiol, 70, 657, 10.1016/0002-9149(92)90208-G · DOI
- Desai, 2013, Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction, Circulation, 128, 209, 10.1161/CIRCULATIONAHA.112.000849 · DOI · Paper page
- Gol, 1997, Septal myectomy in hypertrophic obstructive cardiomyopathy: late results with stress echocardiography, Ann Thorac Surg, 64, 739, 10.1016/S0003-4975(97)00633-4 · doi:10.1016/s0003-4975(97)00633-4
- Havndrup, 2000, Outcome of septal myectomy in patients with hypertrophic obstructive cardiomyopathy, Scand Cardiovasc J, 34, 564, 10.1080/140174300750064486 · DOI
- Heric, 1995, Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results, J Thorac Cardiovasc Surg, 110, 195, 10.1016/S0022-5223(05)80026-1 · DOI · Paper page
- Krajcer, 1989, Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy. Ten-year follow-up in 185 patients, Circulation, 80, 57
- Lisboa, 2011, Long term results of septal myectomy in the treatment of obstructive hypertrophic cardiomyopathy, Rev Bras Cir Cardiovasc, 26, 86, 10.1590/S0102-76382011000100016 · DOI
- Merrill, 2000, Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy, Ann Thorac Surg, 69, 1732, 10.1016/S0003-4975(00)01314-X · doi:10.1016/s0003-4975(00)01314-x
- Minami, 2002, Long term follow-up of surgical treatment of hypertrophic obstructive cardiomyopathy (HOCM): the role of concomitant cardiac procedures, Eur J Cardiothorac Surg, 22, 206, 10.1016/S1010-7940(02)00254-3 · doi:10.1016/s1010-7940(02)00254-3
- Ommen, 2005, Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, 46, 470, 10.1016/j.jacc.2005.02.090 · DOI · Paper page
- Schonbeck, 1998, Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy, Ann Thorac Surg, 65, 1207, 10.1016/S0003-4975(98)00187-8 · DOI
- Schulte, 1993, Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years, J Thorac Cardiovasc Surg, 106, 709, 10.1016/S0022-5223(19)33715-8 · DOI
- Woo, 2005, Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy, Circulation, 111, 2033, 10.1161/01.CIR.0000162460.36735.71 · DOI · Paper page
- Kuhn, 2008, Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience, Clin Res Cardiol, 97, 234, 10.1007/s00392-007-0616-7 · DOI
- Sorajja, 2008, Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation, 118, 131, 10.1161/CIRCULATIONAHA.107.738740 · DOI · Paper page
- Alam, 2009, Hypertrophic obstructive cardiomyopathy alcohol septal ablation vs. myectomy: a meta-analysis, Eur Heart J, 30, 1080, 10.1093/eurheartj/ehp016 · DOI
- Zeng, 2006, Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a meta analysis, Int J Cardiol, 112, 80, 10.1016/j.ijcard.2005.10.009 · DOI
- Faber, 2004, Echo-guided percutaneous septal ablation for symptomatic hypertrophic cardiomyopathy: 7 years of experience, Eur J Echocardiogr, 5, 347, 10.1016/j.euje.2004.01.001 · DOI
- Drake, 2014, Echo-guided mitral reapair, Circ Cardiovasc Imaging, 7, 132, 10.1161/CIRCIMAGING.112.000458 · DOI
- Mohr, 2013, Keynote lecture-transmitral hypertrophic obstructive cardiomyopathy (HOCM) repair, Ann Cardiothorac Surg, 2, 729
- Khalpey, 2014, Robot-assisted septal myectomy for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction, J Thorac Cardiovasc Surg, 147, 1708, 10.1016/j.jtcvs.2013.12.017 · DOI
Cited by
Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. K., Wheeler, M. T., Owens, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31792-x · Cited by 1,296
Self-citationKusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.044 · Cited by 1,008
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643
Kusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000628 · Cited by 603
Metadata
- Authors
- Liebregts, M., Vriesendorp, P. A., Mahmoodi, B. K., Schinkel, A. F. L., Michels, M., & ten Berg, J. M.
- Venue
- JACC: Heart Failure
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 3
- Issue
- 11
- Pages
- 896-905
- ISSN
- 2213-1779 (ISSN-L)
- OpenAlex
- W1846550110
- Cited by
- 216
- References
- 2
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 897 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.